Analyze Diet
Veterinary journal (London, England : 1997)2005; 170(1); 14-23; doi: 10.1016/j.tvjl.2004.04.018

Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)–epidemiology, disease and immunoprophylaxis: a brief review.

Abstract: This review concentrates on the epidemiology, latency and pathogenesis of, and the approaches taken to control infection of horses by equine herpesvirus types 1 (EHV-1) and 4 (EHV-4). Although both viruses may cause febrile rhinopneumonitis, EHV-1 is the main cause of abortions, paresis and neonatal foal deaths. The lesion central to these three conditions is necrotising vasculitis and thrombosis resulting from lytic infection of endothelial cells lining blood capillaries. The initiation of infection in these lesions is likely to be by reactivated EHV-1 from latently infected leukocytes. However, host factors responsible for reactivation remain poorly understood. While vaccine development against these important viruses of equines involving classical and modern approaches has been ongoing for over five decades, progress, compared to other alpha herpesviruses of veterinary importance affecting cattle and pigs, has been slow. However recent data with a live temperature sensitive EHV-1 vaccine show promise.
Publication Date: 2005-07-05 PubMed ID: 15993786DOI: 10.1016/j.tvjl.2004.04.018Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article gives a comprehensive review of the epidemiology, disease manifestation and prevention procedures for the equine herpes viruses 1 (EHV-1) and 4 (EHV-4) in horses, with the EHV-1 known to cause severe conditions including abortions, paralysis, and neonatal deaths.

Epidemiology and Pathogenesis of EHV-1 and EHV-4

  • The research studies the distribution, patterns and causes of EHV-1 and EHV-4 infections in horses. From the data, the herpesvirus types 1 and 4 are prevalent in horses, with EHV-1 causing more severe symptoms.
  • Both EHV-1 and EHV-4 induce a disease known as febrile rhinopneumonitis (a respiratory infection with fever) in horses. However, EHV-1 also engenders more serious health complications like abortions, paralysis (paresis), and neonatal foal deaths.
  • The main pathological marker in these severe conditions is necrotising vasculitis and thrombosis, which is essentially the damage and clotting within the blood vessels. This results from lytic infection (cell rupture and death) of endothelial cells, which make up the lining of blood capillaries, by the herpes viruses.

Latency of EHV-1 and EHV-4

  • The research examines the latency of the viruses, in other words, their ability to become dormant and then reactivate at a later stage. The identification of these inflammatory conditions is largely attributed to the reactivation of latent EHV-1 hiding within leukocytes, which are types of white blood cells.
  • Despite the conclusion, it is not quite clear as to the exact host factors (attributes specific to the horses themselves) that allow for the reactivation of the dormant EHV-1 virus. This component is stated as quite poorly understood in the research.

Immunoprophylaxis: Preventive Measures against EHV-1 and EHV-4

  • This section of the research is dedicated to preventive measures against the EHV-1 and EHV-4 infections in horses, with particular focus on vaccine development.
  • Efforts to create a vaccine against these equine herpes viruses have been going on for over five decades, using both traditional and modern vaccine production methods.
  • However, the progress of these developments is described as relatively slow when compared to advances in vaccine production for other similar alpha herpesviruses affecting cattle and pigs.
  • Despite the slower pace of development, the review mentions promising recent data from a novel EHV-1 vaccine, which employs a live temperature-sensitive strain of the virus, indicating potential for progress in effective immunization against these equine herpesviruses.

Cite This Article

APA
Patel JR, Heldens J. (2005). Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)–epidemiology, disease and immunoprophylaxis: a brief review. Vet J, 170(1), 14-23. https://doi.org/10.1016/j.tvjl.2004.04.018

Publication

ISSN: 1090-0233
NlmUniqueID: 9706281
Country: England
Language: English
Volume: 170
Issue: 1
Pages: 14-23

Researcher Affiliations

Patel, J R
  • Intervet UK Ltd., The Elms, Thicket Road, Houghton, Huntingdon, Cambridgeshire, PE28 2BQ, UK. jay.patel@intervet.com
Heldens, J

    MeSH Terms

    • Animals
    • Global Health
    • Herpesviridae Infections / epidemiology
    • Herpesviridae Infections / prevention & control
    • Herpesviridae Infections / veterinary
    • Herpesvirus 1, Equid / immunology
    • Herpesvirus 4, Equid / immunology
    • Horse Diseases / epidemiology
    • Horse Diseases / prevention & control
    • Horses
    • Vaccination / veterinary
    • Viral Vaccines / therapeutic use

    Citations

    This article has been cited 63 times.
    1. Tombácz D, Torma G, Gulyás G, Fülöp Á, Dörmő Á, Prazsák I, Csabai Z, Mizik M, Hornyák Á, Zádori Z, Kakuk B, Boldogkői Z. Hybrid sequencing discloses unique aspects of the transcriptomic architecture in equid alphaherpesvirus 1.. Heliyon 2023 Jul;9(7):e17716.
      doi: 10.1016/j.heliyon.2023.e17716pubmed: 37449092google scholar: lookup
    2. Kremling V, Loll B, Pach S, Dahmani I, Weise C, Wolber G, Chiantia S, Wahl MC, Osterrieder N, Azab W. Crystal structures of glycoprotein D of equine alphaherpesviruses reveal potential binding sites to the entry receptor MHC-I.. Front Microbiol 2023;14:1197120.
      doi: 10.3389/fmicb.2023.1197120pubmed: 37250020google scholar: lookup
    3. Miglinci L, Reicher P, Nell B, Koch M, Jindra C, Brandt S. Detection of Equine Papillomaviruses and Gamma-Herpesviruses in Equine Squamous Cell Carcinoma.. Pathogens 2023 Jan 23;12(2).
      doi: 10.3390/pathogens12020179pubmed: 36839451google scholar: lookup
    4. Badr C, Souiai O, Arbi M, El Behi I, Essaied MS, Khosrof I, Benkahla A, Chabchoub A, Ghram A. Epidemiological and Phylogeographic Study of Equid Herpesviruses in Tunisia.. Pathogens 2022 Sep 5;11(9).
      doi: 10.3390/pathogens11091016pubmed: 36145448google scholar: lookup
    5. Mureşan A, Mureşan C, Siteavu M, Avram E, Bochynska D, Taulescu M. An Outbreak of Equine Herpesvirus-4 in an Ecological Donkey Milk Farm in Romania.. Vaccines (Basel) 2022 Mar 18;10(3).
      doi: 10.3390/vaccines10030468pubmed: 35335100google scholar: lookup
    6. Tong P, Duan R, Palidan N, Deng H, Duan L, Ren M, Song X, Jia C, Tian S, Yang E, Kuang L, Xie J. Outbreak of neuropathogenic equid herpesvirus 1 causing abortions in Yili horses of Zhaosu, North Xinjiang, China.. BMC Vet Res 2022 Mar 1;18(1):83.
      doi: 10.1186/s12917-022-03171-1pubmed: 35232435google scholar: lookup
    7. Nielsen SS, Alvarez J, Bicout DJ, Calistri P, Canali E, Drewe JA, Garin-Bastuji B, Gonzales Rojas JL, Gortázar C, Herskin M, Michel V, Miranda Chueca MÁ, Roberts HC, Padalino B, Pasquali P, Spoolder H, Ståhl K, Calvo AV, Viltrop A, Winckler C, Carvelli A, Paillot R, Broglia A, Kohnle L, Baldinelli F, Van der Stede Y. Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Equine Herpesvirus-1.. EFSA J 2022 Jan;20(1):e07036.
      doi: 10.2903/j.efsa.2022.7036pubmed: 35035581google scholar: lookup
    8. Agerholm JS, Klas EM, Damborg P, Borel N, Pedersen HG, Christoffersen M. A Diagnostic Survey of Aborted Equine Fetuses and Stillborn Premature Foals in Denmark.. Front Vet Sci 2021;8:740621.
      doi: 10.3389/fvets.2021.740621pubmed: 34859085google scholar: lookup
    9. El Brini Z, Fassi Fihri O, Paillot R, Lotfi C, Amraoui F, El Ouadi H, Dehhaoui M, Colitti B, Alyakine H, Piro M. Seroprevalence of Equine Herpesvirus 1 (EHV-1) and Equine Herpesvirus 4 (EHV-4) in the Northern Moroccan Horse Populations.. Animals (Basel) 2021 Sep 29;11(10).
      doi: 10.3390/ani11102851pubmed: 34679874google scholar: lookup
    10. Altan E, Hui A, Li Y, Pesavento P, Asín J, Crossley B, Deng X, Uzal FA, Delwart E. New Parvoviruses and Picornavirus in Tissues and Feces of Foals with Interstitial Pneumonia.. Viruses 2021 Aug 14;13(8).
      doi: 10.3390/v13081612pubmed: 34452477google scholar: lookup
    11. Bażanów B, Pawęska JT, Pogorzelska A, Florek M, Frącka A, Gębarowski T, Chwirot W, Stygar D. Serological Evidence of Common Equine Viral Infections in a Semi-Isolated, Unvaccinated Population of Hucul Horses.. Animals (Basel) 2021 Jul 30;11(8).
      doi: 10.3390/ani11082261pubmed: 34438717google scholar: lookup
    12. Knox A, Beddoe T. Isothermal Nucleic Acid Amplification Technologies for the Detection of Equine Viral Pathogens.. Animals (Basel) 2021 Jul 20;11(7).
      doi: 10.3390/ani11072150pubmed: 34359278google scholar: lookup
    13. Pavulraj S, Eschke K, Theisen J, Westhoff S, Reimers G, Andreotti S, Osterrieder N, Azab W. Equine Herpesvirus Type 4 (EHV-4) Outbreak in Germany: Virological, Serological, and Molecular Investigations.. Pathogens 2021 Jun 25;10(7).
      doi: 10.3390/pathogens10070810pubmed: 34202127google scholar: lookup
    14. Dayaram A, Seeber PA, Greenwood AD. Environmental Detection and Potential Transmission of Equine Herpesviruses.. Pathogens 2021 Apr 1;10(4).
      doi: 10.3390/pathogens10040423pubmed: 33916280google scholar: lookup
    15. Allkofer A, Garvey M, Ryan E, Lyons R, Ryan M, Lukaseviciute G, Walsh C, Venner M, Cullinane A. Primary vaccination in foals: a comparison of the serological response to equine influenza and equine herpesvirus vaccines administered concurrently or 2 weeks apart.. Arch Virol 2021 Feb;166(2):571-579.
      doi: 10.1007/s00705-020-04846-6pubmed: 33410993google scholar: lookup
    16. Di Francesco CE, Smoglica C, De Amicis I, Cafini F, Carluccio A, Contri A. Evaluation of Colostral Immunity Against Equine Herpesvirus Type 1 (EHV-1) in Martina Franca's Foals.. Front Vet Sci 2020;7:579371.
      doi: 10.3389/fvets.2020.579371pubmed: 33330699google scholar: lookup
    17. Câmara RJF, Bueno BL, Resende CF, Balasuriya UBR, Sakamoto SM, Reis JKPD. Viral Diseases that Affect Donkeys and Mules.. Animals (Basel) 2020 Nov 25;10(12).
      doi: 10.3390/ani10122203pubmed: 33255568google scholar: lookup
    18. Tsai MS, Fogarty U, Byrne AW, O'Keeffe J, Newman C, Macdonald DW, Buesching CD. Effects of Mustelid gammaherpesvirus 1 (MusGHV-1) Reactivation in European Badger (Meles meles) Genital Tracts on Reproductive Fitness.. Pathogens 2020 Sep 20;9(9).
      doi: 10.3390/pathogens9090769pubmed: 32962280google scholar: lookup
    19. Attili AR, Colognato R, Preziuso S, Moriconi M, Valentini S, Petrini S, De Mia GM, Cuteri V. Evaluation of Three Different Vaccination Protocols against EHV1/EHV4 Infection in Mares: Double Blind, Randomized Clinical Trial.. Vaccines (Basel) 2020 Jun 1;8(2).
      doi: 10.3390/vaccines8020268pubmed: 32492841google scholar: lookup
    20. Dunuwille WMB, YousefiMashouf N, Balasuriya UBR, Pusterla N, Bailey E. Genome-wide association study for host genetic factors associated with equine herpesvirus type-1 induced myeloencephalopathy.. Equine Vet J 2020 Nov;52(6):794-798.
      doi: 10.1111/evj.13261pubmed: 32153055google scholar: lookup
    21. Lecollinet S, Pronost S, Coulpier M, Beck C, Gonzalez G, Leblond A, Tritz P. Viral Equine Encephalitis, a Growing Threat to the Horse Population in Europe?. Viruses 2019 Dec 24;12(1).
      doi: 10.3390/v12010023pubmed: 31878129google scholar: lookup
    22. Oladunni FS, Horohov DW, Chambers TM. EHV-1: A Constant Threat to the Horse Industry.. Front Microbiol 2019;10:2668.
      doi: 10.3389/fmicb.2019.02668pubmed: 31849857google scholar: lookup
    23. Schnabel CL, Babasyan S, Rollins A, Freer H, Wimer CL, Perkins GA, Raza F, Osterrieder N, Wagner B. An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.. J Virol 2019 Nov 15;93(22).
      doi: 10.1128/JVI.01011-19pubmed: 31462575google scholar: lookup
    24. Kamel M, Pavulraj S, Osterrieder K, Azab W. EHV-1 Pathogenesis: Current in vitro Models and Future Perspectives.. Front Vet Sci 2019;6:251.
      doi: 10.3389/fvets.2019.00251pubmed: 31417917google scholar: lookup
    25. Azab W, Bedair S, Abdelgawad A, Eschke K, Farag GK, Abdel-Raheim A, Greenwood AD, Osterrieder N, Ali AAH. Detection of equid herpesviruses among different Arabian horse populations in Egypt.. Vet Med Sci 2019 Aug;5(3):361-371.
      doi: 10.1002/vms3.176pubmed: 31149784google scholar: lookup
    26. Holz CL, Sledge DG, Kiupel M, Nelli RK, Goehring LS, Soboll Hussey G. Histopathologic Findings Following Experimental Equine Herpesvirus 1 Infection of Horses.. Front Vet Sci 2019;6:59.
      doi: 10.3389/fvets.2019.00059pubmed: 30886853google scholar: lookup
    27. Stempel M, Chan B, Brinkmann MM. Coevolution pays off: Herpesviruses have the license to escape the DNA sensing pathway.. Med Microbiol Immunol 2019 Aug;208(3-4):495-512.
      doi: 10.1007/s00430-019-00582-0pubmed: 30805724google scholar: lookup
    28. Garvey M, Lyons R, Hector RD, Walsh C, Arkins S, Cullinane A. Molecular Characterisation of Equine Herpesvirus 1 Isolates from Cases of Abortion, Respiratory and Neurological Disease in Ireland between 1990 and 2017.. Pathogens 2019 Jan 15;8(1).
      doi: 10.3390/pathogens8010007pubmed: 30650561google scholar: lookup
    29. Seeber PA, Quintard B, Sicks F, Dehnhard M, Greenwood AD, Franz M. Environmental stressors may cause equine herpesvirus reactivation in captive Grévy's zebras (Equus grevyi).. PeerJ 2018;6:e5422.
      doi: 10.7717/peerj.5422pubmed: 30155350google scholar: lookup
    30. Schnabel CL, Wimer CL, Perkins G, Babasyan S, Freer H, Watts C, Rollins A, Osterrieder N, Wagner B. Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity.. BMC Vet Res 2018 Aug 22;14(1):245.
      doi: 10.1186/s12917-018-1563-4pubmed: 30134896google scholar: lookup
    31. Stasiak K, Dunowska M, Rola J. Prevalence and sequence analysis of equid herpesviruses from the respiratory tract of Polish horses.. Virol J 2018 Jul 11;15(1):106.
      doi: 10.1186/s12985-018-1018-3pubmed: 29996858google scholar: lookup
    32. Amery-Gale J, Hartley CA, Vaz PK, Marenda MS, Owens J, Eden PA, Devlin JM. Avian viral surveillance in Victoria, Australia, and detection of two novel avian herpesviruses.. PLoS One 2018;13(3):e0194457.
      doi: 10.1371/journal.pone.0194457pubmed: 29570719google scholar: lookup
    33. Garvey M, Suárez NM, Kerr K, Hector R, Moloney-Quinn L, Arkins S, Davison AJ, Cullinane A. Equid herpesvirus 8: Complete genome sequence and association with abortion in mares.. PLoS One 2018;13(2):e0192301.
      doi: 10.1371/journal.pone.0192301pubmed: 29414990google scholar: lookup
    34. Shakya AK, O'Callaghan DJ, Kim SK. Comparative Genomic Sequencing and Pathogenic Properties of Equine Herpesvirus 1 KyA and RacL11.. Front Vet Sci 2017;4:211.
      doi: 10.3389/fvets.2017.00211pubmed: 29312962google scholar: lookup
    35. Dayaram A, Franz M, Schattschneider A, Damiani AM, Bischofberger S, Osterrieder N, Greenwood AD. Long term stability and infectivity of herpesviruses in water.. Sci Rep 2017 Apr 21;7:46559.
      doi: 10.1038/srep46559pubmed: 28429732google scholar: lookup
    36. Wagner B, Perkins G, Babasyan S, Freer H, Keggan A, Goodman LB, Glaser A, Torsteinsdóttir S, Svansson V, Björnsdóttir S. Neonatal Immunization with a Single IL-4/Antigen Dose Induces Increased Antibody Responses after Challenge Infection with Equine Herpesvirus Type 1 (EHV-1) at Weanling Age.. PLoS One 2017;12(1):e0169072.
      doi: 10.1371/journal.pone.0169072pubmed: 28045974google scholar: lookup
    37. Izume S, Kirisawa R, Ohya K, Ohnuma A, Kimura T, Omatsu T, Katayama Y, Mizutani T, Fukushi H. The full genome sequences of 8 equine herpesvirus type 4 isolates from horses in Japan.. J Vet Med Sci 2017 Jan 24;79(1):206-212.
      doi: 10.1292/jvms.16-0506pubmed: 27840393google scholar: lookup
    38. Proft A, Spiesschaert B, Izume S, Taferner S, Lehmann MJ, Azab W. The Role of the Equine Herpesvirus Type 1 (EHV-1) US3-Encoded Protein Kinase in Actin Reorganization and Nuclear Egress.. Viruses 2016 Oct 12;8(10).
      doi: 10.3390/v8100275pubmed: 27754319google scholar: lookup
    39. Vaz PK, Horsington J, Hartley CA, Browning GF, Ficorilli NP, Studdert MJ, Gilkerson JR, Devlin JM. Evidence of widespread natural recombination among field isolates of equine herpesvirus 4 but not among field isolates of equine herpesvirus 1.. J Gen Virol 2016 Mar;97(3):747-755.
      doi: 10.1099/jgv.0.000378pubmed: 26691326google scholar: lookup
    40. Taktaz Hafshejani T, Nekoei S, Vazirian B, Doosti A, Khamesipour F, Anyanwu MU. Molecular Detection of Equine Herpesvirus Types 1 and 4 Infection in Healthy Horses in Isfahan Central and Shahrekord Southwest Regions, Iran.. Biomed Res Int 2015;2015:917854.
      doi: 10.1155/2015/917854pubmed: 26421307google scholar: lookup
    41. Bergmann T, Moore C, Sidney J, Miller D, Tallmadge R, Harman RM, Oseroff C, Wriston A, Shabanowitz J, Hunt DF, Osterrieder N, Peters B, Antczak DF, Sette A. The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires.. Immunogenetics 2015 Nov;67(11-12):675-89.
      doi: 10.1007/s00251-015-0872-zpubmed: 26399241google scholar: lookup
    42. Spiesschaert B, Goldenbogen B, Taferner S, Schade M, Mahmoud M, Klipp E, Osterrieder N, Azab W. Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model.. J Virol 2015 Dec;89(23):11899-908.
      doi: 10.1128/JVI.01809-15pubmed: 26378176google scholar: lookup
    43. Laval K, Favoreel HW, Poelaert KC, Van Cleemput J, Nauwynck HJ. Equine Herpesvirus Type 1 Enhances Viral Replication in CD172a+ Monocytic Cells upon Adhesion to Endothelial Cells.. J Virol 2015 Nov;89(21):10912-23.
      doi: 10.1128/JVI.01589-15pubmed: 26292328google scholar: lookup
    44. Badenhorst M, Page P, Ganswindt A, Laver P, Guthrie A, Schulman M. Detection of equine herpesvirus-4 and physiological stress patterns in young Thoroughbreds consigned to a South African auction sale.. BMC Vet Res 2015 Jun 2;11:126.
      doi: 10.1186/s12917-015-0443-4pubmed: 26033323google scholar: lookup
    45. Spiesschaert B, Osterrieder N, Azab W. Comparative analysis of glycoprotein B (gB) of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmission.. Viruses 2015 Feb 3;7(2):522-42.
      doi: 10.3390/v7020522pubmed: 25654240google scholar: lookup
    46. Schulman M, Becker A, Ganswindt S, Guthrie A, Stout T, Ganswindt A. The effect of consignment to broodmare sales on physiological stress measured by faecal glucocorticoid metabolites in pregnant Thoroughbred mares.. BMC Vet Res 2014 Jan 17;10:25.
      doi: 10.1186/1746-6148-10-25pubmed: 24433380google scholar: lookup
    47. Słońska A, Cymerys J, Godlewski MM, Dzieciątkowski T, Tucholska A, Chmielewska A, Golke A, Bańbura MW. Equine herpesvirus type 1 (EHV-1)-induced rearrangements of actin filaments in productively infected primary murine neurons.. Arch Virol 2014 Jun;159(6):1341-9.
      doi: 10.1007/s00705-013-1949-3pubmed: 24352436google scholar: lookup
    48. Azab W, Lehmann MJ, Osterrieder N. Glycoprotein H and α4β1 integrins determine the entry pathway of alphaherpesviruses.. J Virol 2013 May;87(10):5937-48.
      doi: 10.1128/JVI.03522-12pubmed: 23514881google scholar: lookup
    49. Walter J, Seeh C, Fey K, Bleul U, Osterrieder N. Clinical observations and management of a severe equine herpesvirus type 1 outbreak with abortion and encephalomyelitis.. Acta Vet Scand 2013 Mar 5;55(1):19.
      doi: 10.1186/1751-0147-55-19pubmed: 23497661google scholar: lookup
    50. Azab W, El-Sheikh A. The role of equine herpesvirus type 4 glycoprotein k in virus replication.. Viruses 2012 Aug;4(8):1258-63.
      doi: 10.3390/v4081258pubmed: 23012623google scholar: lookup
    51. Azab W, Zajic L, Osterrieder N. The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding.. Vet Res 2012 Aug 21;43(1):61.
      doi: 10.1186/1297-9716-43-61pubmed: 22909178google scholar: lookup
    52. Smith KL, Li Y, Breheny P, Cook RF, Henney PJ, Sells S, Pronost S, Lu Z, Crossley BM, Timoney PJ, Balasuriya UB. New real-time PCR assay using allelic discrimination for detection and differentiation of equine herpesvirus-1 strains with A2254 and G2254 polymorphisms.. J Clin Microbiol 2012 Jun;50(6):1981-8.
      doi: 10.1128/JCM.00135-12pubmed: 22493339google scholar: lookup
    53. Azab W, Osterrieder N. Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins.. J Virol 2012 Feb;86(4):2031-44.
      doi: 10.1128/JVI.06555-11pubmed: 22171258google scholar: lookup
    54. Sasaki M, Kim E, Igarashi M, Ito K, Hasebe R, Fukushi H, Sawa H, Kimura T. Single amino acid residue in the A2 domain of major histocompatibility complex class I is involved in the efficiency of equine herpesvirus-1 entry.. J Biol Chem 2011 Nov 11;286(45):39370-8.
      doi: 10.1074/jbc.M111.251751pubmed: 21949188google scholar: lookup
    55. Glorieux S, Favoreel HW, Steukers L, Vandekerckhove AP, Nauwynck HJ. A trypsin-like serine protease is involved in pseudorabies virus invasion through the basement membrane barrier of porcine nasal respiratory mucosa.. Vet Res 2011 Apr 14;42(1):58.
      doi: 10.1186/1297-9716-42-58pubmed: 21492440google scholar: lookup
    56. Patel JR, Heldens JG. Immunoprophylaxis against important virus disease of horses, farm animals and birds.. Vaccine 2009 Mar 13;27(12):1797-1810.
      doi: 10.1016/j.vaccine.2008.12.063pubmed: 19402200google scholar: lookup
    57. Patel JR, Heldens JG. Review of companion animal viral diseases and immunoprophylaxis.. Vaccine 2009 Jan 22;27(4):491-504.
      doi: 10.1016/j.vaccine.2008.11.027pubmed: 19041354google scholar: lookup
    58. Martín Ocampos GP, Fuentealba NA, Sguazza GH, Jones LR, Cigliano MM, Barbeito CG, Galosi CM. Genomic and phylogenetic analysis of Argentinian Equid Herpesvirus 1 strains.. Virus Genes 2009 Feb;38(1):113-7.
      doi: 10.1007/s11262-008-0301-6pubmed: 19023651google scholar: lookup
    59. Schrenzel MD, Tucker TA, Donovan TA, Busch MD, Wise AG, Maes RK, Kiupel M. New hosts for equine herpesvirus 9.. Emerg Infect Dis 2008 Oct;14(10):1616-9.
      doi: 10.3201/eid1410.080703pubmed: 18826828google scholar: lookup
    60. Rosas C, Van de Walle GR, Metzger SM, Hoelzer K, Dubovi EJ, Kim SG, Parrish CR, Osterrieder N. Evaluation of a vectored equine herpesvirus type 1 (EHV-1) vaccine expressing H3 haemagglutinin in the protection of dogs against canine influenza.. Vaccine 2008 May 2;26(19):2335-43.
      doi: 10.1016/j.vaccine.2008.02.064pubmed: 18407383google scholar: lookup
    61. Van de Walle GR, Jarosinski KW, Osterrieder N. Alphaherpesviruses and chemokines: pas de deux not yet brought to perfection.. J Virol 2008 Jul;82(13):6090-7.
      doi: 10.1128/JVI.00098-08pubmed: 18385255google scholar: lookup
    62. Heldens JG, Patel JR, Chanter N, Ten Thij GJ, Gravendijck M, Schijns VE, Langen A, Schetters TP. Veterinary vaccine development from an industrial perspective.. Vet J 2008 Oct;178(1):7-20.
      doi: 10.1016/j.tvjl.2007.11.009pubmed: 18313956google scholar: lookup
    63. Loregian A, Case A, Cancellotti E, Valente C, Marsden HS, Palù G. Cloning, expression, and functional characterization of the equine herpesvirus 1 DNA polymerase and its accessory subunit.. J Virol 2006 Jul;80(13):6247-58.
      doi: 10.1128/JVI.02551-05pubmed: 16775312google scholar: lookup